- This event has passed.
Dr. Joe Yeong, on Spatial Medicine and Spatial Proteogenomic: a new hope or a new hype?
June 17, 2025 @ 11:00 am - 12:00 pm
Dr. Joe Yeong’s research sits at the intersection between cutting edge spatial technology and clinical translation- you don’t want to miss this event!
Tuesday, June 17th at 11:00-12:00 (Mikroskopie Hörsaal, Institute of Tissue Medicine and Pathology, ON-SITE and on zoom here: https://unibe-ch.zoom.us/j/66103660545?pwd=BBOVI6l73jKywSem6DZBn1qA0YDiaq.1 )
BIOGRAPHY: Dr. Joe Yeong is Director of ImmunoPathology at Singapore General Hospital and Academic Clinical ProgramGroup Leader at SingHealth Duke-NUS Pathology Institute of Molecular and Cell Biology (IMCB, A*STAR, Singapore), Department of Anatomical Pathology, Singapore General Hospital (SGH). Dr. Joe Yeong’s main research focus is to understand and overcome the resistance of cancer immunotherapy, by using advanced technologies and AI. As an immunopathologist, his key vision is to bridge immunologists and pathologists. He is a pioneer in spatial technologies, translated assays to clinic, and has published > 130 papers in the field (Top 2% Scientist) (>100 invited talks internationally). His works on cancer immunology are included in multiple National & international funded studies as well as industry sponsored projects (>20 million dollars since 2017). He served as a committee member in the World Immunotherapy Council, Society for Immunotherapy of Cancer (SITC) and is one of the organizers for its 2019, 2023 & 2025 WIC Global Symposium as well as multiplex IF expert consensus meetings. He also serves as one of the founding-Program Chair of one of the largest AI medical Imaging conferences, CLINICCAI-MICCAI and serves as founding board member of MICCAI SIG-ComPath. He is also having editorial roles of Nature Springer, JITC, JCO (ASCO) and World Scientific (Chief Editor). He serves as a Secretary (Executive) in Singapore Society of Oncology – Cancer Immunotherapy Consortium, Co-lead in Education/Diagnostic of Singhealth Duke-NUS Cell Therapy Centre as well as Advisor (Spatial Technology), Cancer Discovery Hub, National Cancer Centre. In 2023, he co-founded World Immunotherapy Council Asian Chapter for promoting tumor immunology and advancing cancer immunotherapy education, information and research across Asia. He is also a regular reviewer for top journal such as JITC, Mod Path, Lancet and Nature.
Please feel free to disseminate to your institutes and colleagues